| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 | Jan'18 | Oct'17 | Jul'17 | Apr'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||||
Net loss | |||||||||||
-23,752 | -18,237 | -20,813 | -20,592 | -19,183 | -17,224 | -18,545 | -17,789 | -6,045 | -10,365 | -14,841 | -8,126 |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
Depreciation, amortization and accretion | |||||||||||
3,467 | 3,235 | 2,656 | 2,508 | 1,600 | 2,133 | 2,542 | 1,953 | 1,534 | 1,828 | 1,761 | 1,427 |
Stock-based compensation | |||||||||||
13,633 | 11,838 | 11,616 | 7,959 | 7,635 | 7,459 | 5,662 | 4,601 | 2,995 | 3,041 | 1,800 | 1,154 |
Provision for doubtful accounts | |||||||||||
658 | 977 | 908 | 1,344 | -569 | 2,006 | 1,317 | 1,195 | 542 | 2,419 | 0 | 345 |
Other | |||||||||||
- | 381 | 376 | 511 | - | 76 | -144 | 0 | - | - | - | - |
Amortization of deferred commissions | |||||||||||
2,500 | 2,344 | 2,356 | 2,300 | 2,200 | 2,100 | 1,883 | 1,817 | - | - | - | - |
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | |||||||||||
9,460 | 14,145 | -4,648 | -4,453 | 6,310 | 11,331 | -2,017 | -3,181 | 11,785 | 10,619 | -1,784 | 363 |
Prepaid expenses and other assets | |||||||||||
659 | 1,110 | 1,374 | 1,037 | 1,571 | 2,468 | -327 | 2,113 | 3,087 | -160 | 25 | 242 |
Deferred commissions | |||||||||||
4,617 | 3,009 | 1,861 | 1,924 | 4,633 | 3,076 | 2,973 | 2,874 | - | - | - | - |
Other assets | |||||||||||
- | - | -627 | 1,440 | - | - | -114 | 1,995 | - | 491 | 51 | 25 |
Accounts payable | |||||||||||
645 | 437 | -669 | 4 | -1,129 | -133 | -871 | 1,030 | -704 | 36 | -2,001 | -1,105 |
Accrued expenses and other liabilities | |||||||||||
-6,234 | 7,974 | -2,022 | 909 | 1,645 | 1,585 | 690 | 1,936 | 761 | 1,753 | 941 | 932 |
Accrued employee liabilities | |||||||||||
-3,034 | 4,603 | -3,617 | 3,638 | -1,913 | 3,540 | 3,593 | -318 | 3,143 | 1,585 | 1,377 | 266 |
Deferred revenue | |||||||||||
18,199 | 8,043 | -2,197 | 1,477 | 14,170 | 8,004 | 1,413 | 1,102 | 10,091 | 5,834 | 607 | 1,435 |
Other long-term liabilities | |||||||||||
- | - | 1,178 | -1,256 | - | - | 251 | 448 | - | -40 | -12 | -56 |
Net cash used in operating activities | |||||||||||
4,009 | 3,509 | -8,946 | -2,162 | -6,989 | -6,370 | -2,396 | -7,826 | -6,899 | -4,859 | -8,660 | -4,358 |
Cash flows from investing activities: | |||||||||||
Purchases of property and equipment | |||||||||||
8,546 | 8,636 | 2,566 | 1,676 | 2,791 | 3,931 | 4,926 | 1,764 | 2,218 | 822 | 947 | 711 |
Purchases of short-term investments | |||||||||||
28,697 | 52,863 | 35,368 | 67,705 | 10,346 | 97,118 | 0 | 0 | - | - | - | - |
Sales of short-term investments | |||||||||||
1 | 0 | 0 | 3,496 | 0 | 0 | 0 | 0 | - | - | - | - |
Maturities of short-term investments | |||||||||||
17,000 | 65,400 | 34,500 | 55,900 | 0 | 0 | 0 | 0 | - | - | - | - |
Net cash used in investing activities | |||||||||||
-20,242 | 3,901 | -3,434 | -9,985 | -13,137 | -101,049 | -5,173 | -1,764 | -2,218 | -822 | -12,367 | -711 |
Cash flows from financing activities: | |||||||||||
Payments under capital leases | |||||||||||
0 | 0 | 0 | 0 | 2,287 | 872 | 228 | 236 | 655 | 523 | 368 | 535 |
Proceeds from issuance of common stock upon exercise of stock options | |||||||||||
3,098 | 1,933 | 2,202 | 4,846 | 2,455 | 2,361 | 916 | 5,749 | 1,822 | 447 | 879 | 1,305 |
Repurchases of unvested common stock | |||||||||||
49 | 23 | 7 | 40 | 8 | 4 | 0 | 6 | - | - | - | - |
Payments of offering costs | |||||||||||
0 | 0 | 0 | 0 | 0 | 127 | 2,380 | 1,892 | - | - | - | - |
Proceeds from initial public offering, net of underwriters’ discounts and commissions | |||||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 164,703 | - | - | - | - |
Payments under related party notes receivable | |||||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,344 | - | - | - | - |
Net cash provided by financing activities | |||||||||||
5,850 | 801 | 6,523 | 4,806 | 5,489 | 6,566 | -14,667 | 163,974 | -704 | -111 | 15,460 | 770 |
Effect of exchange rates on cash and cash equivalents and restricted cash | |||||||||||
37 | -141 | -200 | -75 | 344 | -679 | 416 | -78 | 566 | 73 | 155 | 166 |
Net (decrease) increase in cash and cash equivalents and restricted cash | |||||||||||
-10,346 | 8,070 | -6,057 | -7,416 | -14,293 | -101,532 | -21,820 | 154,306 | -9,255 | -5,719 | -5,412 | -4,133 |
Supplemental disclosure of non-cash investing and financing activities: | |||||||||||
Property and equipment acquired under capital leases | |||||||||||
- | - | - | - | - | - | - | - | 156 | 0 | 0 | 488 |
Lapse in restrictions on early exercised common stock options | |||||||||||
47 | 59 | 101 | 205 | 337 | 614 | 304 | 833 | 308 | 137 | 133 | 156 |
Property and equipment purchases accrued or in accounts payable | |||||||||||
555 | 2,157 | 611 | 288 | -60 | -702 | 1,034 | 35 | 107 | -2 | 35 | 31 |
Deferred offering costs payable or accrued but not paid | |||||||||||
0 | 0 | 0 | 0 | 0 | -127 | -1,844 | 2,181 | - | - | - | - |